Risk factors for cerebral stroke;Risikofaktorer for hjerneslag

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 6, 2007, Pages 748-750

  Mathiesen, Ellisiv Bøgeberg ^a,b   Njølstad, Inger ^a   Joakimsen, Oddmund ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b Haukeland universitetssykehus   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947195771     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37: 1583-633.
2. Ellekjær H, Holmen J, Indredavik B et al. Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and case-fatality rate. Stroke 1997; 28: 2180-4.
3. Njølstad I, Arnesen E, Lund-Larsen PG. Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark study. Circulation 1996; 94: 2877-82.
4. Flossmann E, Schulz UGR, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004; 35: 212-27.
5. Gretarsdottir S, Thorleifsson G, Reynisdottir ST et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003; 35: 131-8.
6. Helgadottir A, Manolescu A, Thorleifsson G et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36: 233-9.
7. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-71.
8. Psaty BM, Smith NL, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277: 739-45.
9. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789-4.
10. Hankey GJ. Smoking and risk of stroke. J Cardiovasc Risk 1999; 6: 207-11.
11. Chambless LE, Heiss G, Shahar E, et al. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2004; 160: 259-69.
12. Iso H, Jacobs DR, Wentworth D et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. New Engl J Med 1989; 320: 904-10.
13. Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000; 31: 1882-8.
14. Burchfiel CM, Curb JD, Rodriguez BL et al. Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke 1994; 25: 951-7.
15. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 2005; 36: 891-901.
16. Walker SP, Rimm EB, Ascherio A et al. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996; 144: 1143-50.
17. Yaggi HK, Concato J, Kernan WN et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-41.
18. Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.
19. Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis. The Tromsø Study. Circulation 2001; 103: 2171-5.
20. Cox AM, McKevitt C, Rudd AG et al. Socioeconomic status and stroke. Lancet Neurol 2006; 5: 181-8.
21. Avendano M, Kawachi I, van Lenthe F et al. Socioeconomic status and stroke incidence in the US elderly. The role of risk factors in the EPESE Study. Stroke 2006; 37: 1368-73.
22. Gillum RF, Mussolino ME, Ingram DD. Physical activity and stroke incidence in women and men. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1996; 143: 860-9.
23. Reynolds K, Lewis LB, Nolen JD et al. Alcohol consumption and risk of stroke: A meta-analysis. JAMA 2003; 289: 579-88.
24. Etminan M, Takkouche B, Isorna FC et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330: 63.
25. Bath PMW, Gray LJ. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005; 330: 342.
26. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a metaanalysis. JAMA 2000; 284: 72-8.
27. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294: 1799-809.
28. Kuo HK, Yen CJ, Chang CH et al. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005; 4: 371-80.
29. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015-22.